Institutional Ownership
Nervgen Pharma Corp
CUSIP 64082X203COMQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
44
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Pfg Investments, LLC | 201.0K | $757.8K |
| 2 | Bank Of America Corp /De/ | 200.7K | $756.5K |
| 3 | Marshall Wace, LLP | 200.4K | $755.4K |
| 4 | Royal Bank Of Canada | 172.0K | $648.0K |
| 5 | Integrated Wealth Concepts LLC | 86.8K | $327.3K |
| 6 | Valley Forge Investment Consultants Inc Adv | 77.7K | $292.9K |
| 7 | Bank Of Montreal /Can/ | 62.9K | $237.1K |
| 8 | Captrust Financial Advisors | 62.4K | $235.1K |
| 9 | Ubs Group AG | 61.5K | $231.9K |
| 10 | Osaic Holdings, Inc. | 40.0K | $150.8K |